All Access Articles |
- Harrow, Inc. Appoints New Leadership at ImprimisRx | 2025-10-06 | PHARMACEUTICAL
- Company X Reports 15% Revenue Growth | 2025-09-28 | PHARMACEUTICAL
- HARROW, INC. Announces Pricing of $250M Senior Notes | 2025-09-09 | PHARMACEUTICAL